When to Stop Apixaban and Aspirin Before Surgery
Stop apixaban 24 hours before low-bleeding-risk procedures and 48 hours before high-bleeding-risk procedures; stop aspirin 5-7 days before surgery unless cardiovascular risk outweighs bleeding risk, in which case continue it perioperatively.
Apixaban Management
Preoperative Discontinuation
The FDA-approved apixaban label provides the clearest guidance: discontinue apixaban at least 24 hours prior to elective surgery or invasive procedures with low bleeding risk, and at least 48 hours prior to procedures with moderate or high bleeding risk 1. This recommendation is strongly supported by the 2022 American College of Chest Physicians (ACCP) guidelines, which recommend stopping apixaban 1 day before low-to-moderate-bleed-risk surgery and 2 days before high-bleed-risk surgery 2.
The 2014 Canadian Cardiovascular Society guidelines align with this approach, suggesting 1-2 days interruption for low bleeding risk and 2-3 days for intermediate/high bleeding risk 3. Multiple expert consensus statements from Blood (2012) consistently support this timing 4.
Key consideration: Unlike dabigatran, apixaban does not require extended interruption periods based on renal function, as only 25% is renally cleared 4.
Evidence Supporting Shorter Interruption
The PAUSE trial (2019) demonstrated that this abbreviated interruption strategy is safe, with 30-day arterial thromboembolism rates of only 0.16% and major bleeding rates of 1.35% in apixaban-treated patients 5. A 2022 prospective cohort study (ADIOS) confirmed that 94% of patients achieved clinically insignificant apixaban levels (≤30 ng/mL) with median cessation time of 76 hours 6.
No Bridging Required
Bridging anticoagulation with heparin is not recommended during the 24-48 hour apixaban interruption period 2, 1. The rapid offset and onset of DOACs eliminates the need for bridging therapy that was previously standard with warfarin 2.
Aspirin Management
Preoperative Discontinuation
Stop aspirin 5-7 days before most elective procedures when bleeding risk is significant 3. For very high bleeding-risk procedures, extend discontinuation to 7-10 days 3. The 2012 ACCP guidelines support stopping aspirin 7-10 days before surgery in patients at low cardiovascular risk 7.
When to Continue Aspirin
Continue aspirin perioperatively in these specific situations:
- Secondary prevention of cardiovascular disease in patients at moderate-to-high cardiovascular risk undergoing noncardiac surgery 7, 8
- Recent stroke/TIA - neurological consultation recommended to evaluate competing risks 9
- Coronary artery bypass grafting (CABG) - continue aspirin throughout 7
- Minor procedures with acceptable bleeding risk (dental, dermatologic, cataract surgery) 7
- Within 12 months of drug-eluting stent or 3 months of bare-metal stent placement 9, 8
The 2014 ACC/AHA perioperative guidelines note that continuation versus discontinuation should be determined by consensus between treating clinicians and the patient, weighing cardiac event risk against bleeding risk 8.
Critical Timing Considerations
Multiple studies demonstrate that stopping aspirin too close to surgery (3-7 days) still carries increased bleeding risk 10, 11. One study found optimal timing was 4-5 days for secondary prevention patients, though this requires platelet function testing 11. For spine surgery specifically, stopping aspirin 10 days preoperatively is recommended to avoid catastrophic epidural hematoma 10.
Postoperative Resumption
Apixaban Restart
Resume apixaban 24 hours after low-bleeding-risk surgery and 48-72 hours after high-bleeding-risk surgery once adequate hemostasis is established 4, 2, 1. The FDA label explicitly states to restart "as soon as adequate hemostasis has been established" 1.
For high-risk procedures, consider using a reduced dose (2.5 mg twice daily) for the first 2-3 days in patients at high thromboembolism risk, then increase to full dose 4.
Aspirin Restart
Resume aspirin 24-48 hours after low-bleeding-risk procedures and 48-72 hours after high-bleeding-risk procedures once hemostasis is established 3.
Common Pitfalls to Avoid
- Do not perform neuraxial anesthesia (spinal/epidural) with residual apixaban effect - wait full 48-72 hours for high-risk procedures 12, 1
- Do not bridge apixaban with heparin - this increases bleeding risk without reducing thrombotic events 2
- Do not stop aspirin in patients with recent coronary stents - risk of stent thrombosis outweighs bleeding risk 9, 8
- Do not assume all patients need aspirin stopped - continuation may be safer in high cardiovascular risk patients 7, 8
- Avoid NSAIDs perioperatively - they dramatically increase bleeding risk when combined with anticoagulants (HR 10.25) 13
Risk Stratification Framework
High bleeding risk procedures include: cardiac/intracranial/spinal surgery, major cancer surgery, bowel resection, nephrectomy, any procedure >45 minutes, neuraxial anesthesia 2.
Low-to-moderate bleeding risk procedures include: arthroscopy, laparoscopic cholecystectomy, colonoscopy with biopsy, hernia repair, cataract surgery 2.
Minimal bleeding risk procedures include: minor dental/dermatologic procedures, pacemaker implantation - these can often be performed without stopping anticoagulation 7, 2.